189 related articles for article (PubMed ID: 21299899)
1. Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.
Okwen MP; Ngem BY; Alomba FA; Capo MV; Reid SR; Ewang EC
Harm Reduct J; 2011 Feb; 8():4. PubMed ID: 21299899
[TBL] [Abstract][Full Text] [Related]
2. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China.
Murakami H; Kobayashi M; Zhu X; Li Y; Wakai S; Chiba Y
Soc Sci Med; 2003 Nov; 57(10):1821-32. PubMed ID: 14499508
[TBL] [Abstract][Full Text] [Related]
3. Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.
Ali Khan A; Munir M; Miraj F; Imran S; Arif Siddiqi D; Altaf A; Khan AJ; Chandir S
Hum Vaccin Immunother; 2021 Sep; 17(9):3247-3258. PubMed ID: 33989509
[TBL] [Abstract][Full Text] [Related]
4. Rapid assessment of injection practices in Cambodia, 2002.
Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
[TBL] [Abstract][Full Text] [Related]
5. Safer injections, fewer infections: injection safety in rural north India.
Kermode M; Holmes W; Langkham B; Thomas MS; Gifford S
Trop Med Int Health; 2005 May; 10(5):423-32. PubMed ID: 15860088
[TBL] [Abstract][Full Text] [Related]
6. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
[TBL] [Abstract][Full Text] [Related]
7. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.
Aylward B; Kane M; McNair-Scott R; Hu DJ; Hu DH
Int J Epidemiol; 1995 Apr; 24(2):446-52. PubMed ID: 7635609
[TBL] [Abstract][Full Text] [Related]
8. Reuse of syringes for therapeutic injections in Pakistan: rethinking determinants.
Khan A; Altaf A; Qureshi H; Orakzai M; Khan A
East Mediterr Health J; 2020 Mar; 26(3):283-289. PubMed ID: 32281637
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from a community based intervention to improve injection safety in Pakistan.
Altaf A; Shah SA; Shaikh K; Constable FM; Khamassi S
BMC Res Notes; 2013 Apr; 6():159. PubMed ID: 23607289
[TBL] [Abstract][Full Text] [Related]
10. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
[TBL] [Abstract][Full Text] [Related]
11. Patient Notification Events Due to Syringe Reuse and Mishandling of Injectable Medications by Health Care Personnel-United States, 2012-2018: Summary and Recommended Actions for Prevention and Response.
Schaefer MK; Perkins KM; Perz JF
Mayo Clin Proc; 2020 Feb; 95(2):243-254. PubMed ID: 31883694
[TBL] [Abstract][Full Text] [Related]
12. Injection practices in Nepal: health policymakers' perceptions.
Gyawali S; Rathore DS; Shankar PR; Maskey M; Vikash KK
BMC Int Health Hum Rights; 2014 Jun; 14():21. PubMed ID: 24957575
[TBL] [Abstract][Full Text] [Related]
13. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
14. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses.
Kermode M
Health Promot Int; 2004 Mar; 19(1):95-103. PubMed ID: 14976177
[TBL] [Abstract][Full Text] [Related]
15. Patient notification for bloodborne pathogen testing due to unsafe injection practices in the US health care settings, 2001-2011.
Guh AY; Thompson ND; Schaefer MK; Patel PR; Perz JF
Med Care; 2012 Sep; 50(9):785-91. PubMed ID: 22525612
[TBL] [Abstract][Full Text] [Related]
16. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
Steinglass R; Boyd D; Grabowsky M; Laghari AG; Khan MA; Qavi A; Evans P
Bull World Health Organ; 1995; 73(1):57-63. PubMed ID: 7704926
[TBL] [Abstract][Full Text] [Related]
17. Injection practices in Romania: progress and challenges.
Dentinger C; Pasat L; Popa M; Hutin YJ; Mast EE
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):30-5. PubMed ID: 14756216
[TBL] [Abstract][Full Text] [Related]
18. Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS).
Hayashi T; Hutin YJ; Bulterys M; Altaf A; Allegranzi B
BMC Health Serv Res; 2019 Aug; 19(1):600. PubMed ID: 31455315
[TBL] [Abstract][Full Text] [Related]
19. Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.
Janjua NZ; Butt ZA; Mahmood B; Altaf A
World J Gastroenterol; 2016 Jul; 22(25):5837-52. PubMed ID: 27433097
[TBL] [Abstract][Full Text] [Related]
20. Improved injection safety after targeted interventions in the Syrian Arab Republic.
Mantel C; Khamassi S; Baradei K; Nasri H; Mohsni E; Duclos P
Trop Med Int Health; 2007 Mar; 12(3):422-30. PubMed ID: 17313514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
